MedTrace Logo

SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register

NCT02301689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4749

Last updated 2020-04-09

No results posted yet for this study

Summary

The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions:

How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?

Conditions

  • Heart Failure (HF)

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Olaf Oldenburg, MD · Heart and Diabetes Centre NRW

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-12-31
Completion
2018-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301689 on ClinicalTrials.gov